Longitudinal analysis of CD8+ T-cell phenotype and IL-7, IL-15 and IL-16 mRNA expression in different tissues during primary simian immunodeficiency virus infection

Microbes and Infection

Volumn 3, Issue 3, 2001, Pages 181-191

  Caufour, Philippe ^a   Le Grand, Roger ^a,c   Chéret, Arnaud ^a   Neildez, Olivier ^a   Thiébot, Hugues ^a   Théodoro, Frédéric ^a   Boson, Bertrand ^a   Vaslin, Bruno ^a   Venet, Alain ^b   Dormont, Dominique ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c DSV/DRM   (France)

Author keywords

Cellular immunity; Macaque; Primary infection; SIV

Indexed keywords

CD28 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 7; MESSENGER RNA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CELL COUNT; CONTROLLED STUDY; IMMUNOPATHOGENESIS; INOCULATION; LONGITUDINAL STUDY; LUNG LAVAGE; LYMPH NODE; MONKEY; MONONUCLEAR CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS INFECTION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; TARGET CELL; TISSUE DISTRIBUTION; VIRUS REPLICATION;

EID: 0035008810     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(01)01370-3     Document Type: Article

References (55)

1. Pantaleo G., Graziosi C., Fauci A.S. New concepts in the immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. M. 328:1993;327-335.
2. Yang O.O., Walker B.D. CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication. Adv. Immunol. 66:1997;273-311.
3. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., Racz P., Tenner-Racz K., Dalesandro M., Scallon B.J., Ghrayeb J., Forman M.A., Montefiori D.C., Rieber E.P., Letvin N.L., Reimann K.A. Control of viremia in simian immunodeficiency virus infection by CD8(+) lymphocytes. Science. 283:1999;857-860.
4. Giorgi J.V., Detels R. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. Clin. Immunol. Immunopathol. 52:1989;10-18.
5. Levacher M., Hulstaert F., Tallet S., Ullery S., Pocidalo J.J., Bach B.A. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin. Exp. Immunol. 90:1992;376-382.
6. Borthwick N.J., Bofill M., Gombert W.M., Akbar A.N., Medina E., Sagawa K., Lipman M.C., Johnson M.A., Janossy G. Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS. 8:1994;431-441.
7. Saukkonen J.J., Kornfeld H., Berman J.S. Expansion of a CD8+ CD28- cell population in the blood and lung of HIV-positive patients. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 6:1993;1194-1204.
8. Bofill M., Lipman M., McLaughlin J.E., Johnson M.A., Poulter L.W. Changes in lung lymphocyte populations reflect those seen in peripheral blood in HIV-1 positive individuals. Eur. Respir. J. 11:1998;548-553.
9. Wilson J.D., Ogg G.S., Allen R.L., Goulder P.J., Kelleher A., Sewell A.K., OCallaghan C.A., Rowland-Jones S.L., Callan M.F., McMichael A.J. Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific. J. Exp. M. 188:1998;785-790.
10. Roos M.T., de Leeuw N.A., Claessen F.A., Huisman H.G., Kootstra N.A., Meyaard L., Schellekens P.T., Schuitemaker H., Miedema F. Viro-immunological studies in acute HIV-1 infection. AIDS. 8:1994;1533-1538.
11. Pantaleo G., Demarest J.F., Soudeyns H., Graziosi C., Denis F., Adelsberger J.W., Borrow P., Saag M.S., Shaw G.M., Sekaly R.P. Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature. 370:1994;463-467.
12. Brugnoni D., Prati E., Malacarne F., Gorla R., Airo P., Cattaneo R. The primary response to HIV infection is characterized by an expansion of activated CD8+ CD28- cells. AIDS. 10:1996;104-106.
13. Mankowski J.L., Carter D.L., Spelman J.P., Nealen M.L., Maughan K.R., Kirstein L.M., Didier P.J., Adams R.J., Murphey-Corb M., Zink M.C. Pathogenesis of simian immunodeficiency virus pneumonia: an immunopathological response to virus. Am. J. Pathol. 153:1998;1123-1130.
14. Rosenberg Y.J., Cafaro A., Brennan T., Greenhouse J.G., McKinnon K., Bellah S., Yalley-Ogunro J., Gartner S., Lewis M.G. Characteristics of the CD8+ lymphocytosis during primary simian immunodeficiency virus infections. AIDS. 11:1997;959-968.
15. Chéret A., Le Grand R., Caufour P., Dereuddre-Bosquet N., Matheux F., Neildez O., Théodoro F., Maestrali N., Benveniste O., Vaslin B., Dormont D. Cytokine mRNA expression in mononuclear cells from different tissues during acute SIVmac251 infection of macaques. AIDS Res. Hum. Retroviruses. 12:1996;1263-1272.
16. Reimann K.A., Snyder G.B., Chalifoux L.V., Waite B.C., Miller M.D., Yamamoto H., Spertini O., Letvin N.L. An activated CD8+ lymphocyte appears in lymph nodes of rhesus monkeys early after infection with simian immunodeficiency virus. J. Clin. Invest. 88:1991;1113-1120.
17. Chen Z.W., Kou Z.C., Lekutis C., Shen L., Zhou D., Halloran M., Li J., Sodroski J., Lee-Parritz D., Letvin N.L. T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian- human immunodeficiency virus. J. Exp. M. 182:1995;21-31.
18. Wilson J.D., Cranage M., Cook N., Leech S., McMichael A.J., Callan M.F. Evidence for the persistence of monoclonal expansions of CD8+ T cells following primary simian immunodeficiency virus infection. Eur. J. Immunol. 28:1998;1172-1180.
19. Costello R., Imbert J., Olive D. Interleukin-7, a major T-lymphocyte cytokine. Eur. Cytokine Netw. 4:1993;253-262.
20. Kennedy M.K., Park L.S. Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex. J. Clin. Immunol. 16:1996;134-143.
21. Cruikshank W.W., Kornfeld H., Center D.M. Signaling and functional properties of interleukin-16. Int. Rev. Immunol. 16:1998;523-540.
22. Yoshikai Y., Nishimura H. The role of interleukin 15 in mounting an immune response against microbial infections. Microbes Infect. 2:2000;381-389.
23. Ferrari G., King K., Rathbun K., Place C.A., Packard M.V., Bartlett J.A., Bolognesi D.P., Weinhold K.J. IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp). Clin. Exp. Immunol. 101:1995;239-248.
24. Carini C., Essex M. Interleukin 2-independent interleukin 7 activity enhances cytotoxic immune response of HIV-1-infected individuals. AIDS Res. Hum. Retroviruses. 10:1994;121-130.
25. Kanai T., Thomas E.K., Yasutomi Y., Letvin N.L. IL-15 stimulates the expansion of AIDS virus-specific CTL. J. Immunol. 157:1996;3681-3687.
26. Vingerhoets J., Bisalinkumi E., Penne G., Colebunders R., Bosmans E., Kestens L., Vanham G. Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection. Immunol. Lett. 61:1998;53-61.
27. Bulfone-Paus S., Ungureanu D., Pohl T., Lindner G., Paus R., Ruckert R., Krause H., Kunzendorf U. Interleukin-15 protects from lethal apoptosis in vivo. Nat. M. 3:1997;1124-1128.
28. Boussiotis V.A., Barber D.L., Nakarai T., Freeman G.J., Gribben J.G., Bernstein G.M., DAndrea A.D., Ritz J., Nadler L.M. Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. Science. 266:1994;1039-1042.
29. Baier M., Werner A., Bannert N., Metzner K., Kurth R. HIV suppression by interleukin-16. Nature. 378:1995;563-563.
30. Zhou P., Goldstein S., Devadas K., Tewari D., Notkins A.L., Human C.D. 4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nat. M. 3:1997;659-664.
31. Brinchmann J.E., Dobloug J.H., Heger B.H., Haaheim L.L., Sannes M., Egeland T. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations. J. Infect. Dis. 169:1994;730-738.
32. Fiorentino S., Dalod M., Olive D., Guillet J.G., Gomard E. Predominant involvement of CD8+ CD28- lymphocytes in human immunodeficiency virus-specific cytotoxic activity. J. Virol. 70:1996;2022-2026.
33. Effros R.B., Allsopp R., Chiu C.P., Hausner M.A., Hirji K., Wang L., Harley C.B., Villeponteau B., West M.D., Giorgi J.V. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS. 10:1996;F17-22.
34. Tenner-Racz K., Racz P., Thome C., Meyer C.G., Anderson P.J., Schlossman S.F., Letvin N.L. Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients. Am. J. Pathol. 142:1993;1750-1758.
35. Anderson P., Nagler-Anderson C., OBrien C., Levine H., Watkins S., Slayter H.S., Blue M.L., Schlossman S.F. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J. Immunol. 144:1990;574-582.
36. Groeneveld K., te Marvelde J.G., van den Beemd M.W., Hooijkaas H., van Dongen J.J. Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes. Leukemia. 10:1996;1383-1389.
37. Benveniste O., Vaslin B., Le Grand R., Chéret A., Matheux F., Théodoro F., Cranage M.P., Dormont D. Comparative interleukin (IL)-2/interferon (IFN)-γ and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SIVmac251 virus. Proc. Natl. Acad. Sci. USA. 93:1996;3658-3663.
38. Mugnaini E.N., Spurkland A., Egeland T., Sannes M., Brinchmann J.E. Demonstration of identical expanded clones within both CD8+CD28+ and CD8+CD28- T cell subsets in HIV type 1-infected individuals. Eur. J. Immunol. 28:1998;1738-1742.
39. Dalod M., Sinet M., Deschemin J.C., Fiorentino S., Venet A., Guillet J.G. Altered ex vivo balance CD28+ and CD28- cells within HIV-specific CD8+ T cells of HIV-seropositive patients. Eur. J. Immunol. 29:1999;38-44.
40. Agostini C., Trentin L., Sancetta R., Facco M., Tassinari C., Cerutti A., Bortolin M., Milani A., Siviero M., Zambello R., Semenzato G. Interleukin-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with acquired immunodeficiency syndrome. Blood. 90:1997;1115-1123.
41. Agostini C., Zambello R., Facco M., Perin A., Piazza F., Siviero M., Basso U., Bortolin M., Trentin L., Semenzato G. CD8 T-Cell Infiltration in extravascular tissues of patients with human immunodeficiency virus infection. Interleukin-15 upmodulates costimulatory pathways involved in the antigen-presenting cells-T-cell interaction. Blood. 93:1999;1277-1286.
42. McInnes I.B., Liew F.Y. Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis. Immunol. Today. 19:1998;75-79.
43. Wilkinson P.C., Liew F.Y. Chemoattraction of human blood T lymphocytes by interleukin-15. J. Exp. M. 181:1995;1255-1259.
44. Maciaszek J.W., Parada N.A., Cruikshank W.W., Center D.W., Kornfeld H., Viglianti G.A. IL-16 represses HIV-1 promoter activity. J. Immunol. 158:1997;5-8.
45. Scala E., DOffizi G., Rosso R., Turriziani O., Ferrara R., Mazzone A.M., Antonelli G., Aiuti F., Paganelli R. C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. J. Immunol. 158:1997;4485-4492.
46. Ennen J., Findeklee H., Dittmar M.T., Norley S., Ernst M., Kurth R. CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proc. Natl. Acad. Sci. USA. 91:1994;7207-7211.
47. Chéret A., Le Grand R., Caufour P., Neildez O., Matheux F., Théodoro F., Boussin F., Vaslin B., Dormont D. Chemoattractant factors (IP-10, MIP-1α, IL-16) mRNA expression in mononuclear cells from different tissues during acute SIVmac251 infection of macaques. J. Med. Primatol. 26:1997;19-26.
48. Lifson J.D., Nowak M.A., Goldstein S., Rossio J.L., Kinter A., Vasquez G., Wiltrout T.A., Brown C., Schneider D., Wahl L., Lloyd A.L., Williams J., Elkins W.R., Fauci A.S., Hirsch V.M. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J. Virol. 71:1997;9508-9514.
49. Amiel C., Darcissac E., Truong M.J., Dewulf J., Loyens M., Mouton Y., Capron A., Bahr G.M. Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression. J. Infect. Dis. 179:1999;83-91.
50. Walker B.D., Chakrabarti S., Moss B., Paradis T.J., Flynn T., Durno A.G., Blumberg R.S., Kaplan J.C., Hirsch M.S., Schooley R.T. HIV-specific T lymphocytes in seropositive individuals. Nature. 328:1987;345-348.
51. Gotch F.M., Nixon D.F., Alp N., McMichael A.J., Borysiewicz L.K. High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int. Immunol. 2:1990;707-712.
52. Moss P.A., Rowland-Jones S.L., Frodsham P.M., McAdam S., Giangrande P., McMichael A.J., Bell J.I. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc. Natl. Acad. Sci. USA. 92:1995;5773-5777.
53. Hoffenbach A., Langlade-Demoyen P., Dadaglio G., Vilmer E., Michel F., Mayaud C., Autran B., Plata F. Unusually high frequencies of HIV-specific cytotoxic lymphocytes in humans. J. Immunol. 142:1989;452-462.
54. Cohen O.J., Pantaleo G., Lam G.K., Fauci A.S. Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies. Semin. Immunopathol. 18:1997;305-322.
55. Agostini C., Zambello R., Trentin L., Semenzato G. HIV and pulmonary immune responses. Immunol. Today. 17:1996;359-364.